| 000 | 01605 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514194529.0 | ||
| 264 | 0 | _c20040914 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0041-008X | ||
| 024 | 7 |
_a10.1016/j.taap.2003.10.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamauchi, Hiroshi | |
| 245 | 0 | 0 |
_aEvaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cAug 2004 |
||
| 300 |
_a291-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a8-Hydroxy-2'-Deoxyguanosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aArsenic Poisoning _xmetabolism |
| 650 | 0 | 4 | _aArsenic Trioxide |
| 650 | 0 | 4 |
_aArsenicals _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDNA Damage _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGrowth Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxides _xadministration & dosage |
| 700 | 1 | _aAminaka, Yoshito | |
| 700 | 1 | _aYoshida, Katsumi | |
| 700 | 1 | _aSun, Guifan | |
| 700 | 1 | _aPi, Jingbo | |
| 700 | 1 | _aWaalkes, Michael P | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 198 _gno. 3 _gp. 291-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2003.10.021 _zAvailable from publisher's website |
| 999 |
_c14978162 _d14978162 |
||